<VariationArchive VariationID="4002" VariationName="NM_003748.4(ALDH4A1):c.1560dup (p.Gly521fs)" VariationType="Duplication" Accession="VCV000004002" Version="30" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-15" DateCreated="2015-03-16" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19041" VariationID="4002">
      <GeneList>
        <Gene Symbol="ALDH4A1" FullName="aldehyde dehydrogenase 4 family member A1" GeneID="8659" HGNC_ID="HGNC:406" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="18871430" stop="18902555" display_start="18871430" display_stop="18902555" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="19197923" stop="19229292" display_start="19197923" display_stop="19229292" Strand="-" />
          </Location>
          <OMIM>606811</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003748.4(ALDH4A1):c.1560dup (p.Gly521fs)</Name>
      <CanonicalSPDI>NC_000001.11:18874481:AAA:AAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p36.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="18874481" stop="18874482" display_start="18874481" display_stop="18874482" variantLength="1" positionVCF="18874481" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="19200975" stop="19200976" display_start="19200975" display_stop="19200976" variantLength="1" positionVCF="19200975" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>G521fs</ProteinChange>
      <ProteinChange>G461fs</ProteinChange>
      <ProteinChange>G470fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.19200978dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.19200978dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.18874484dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.18874484dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012283.1" sequenceAccession="NG_012283" sequenceVersion="1" change="g.33318dup">
            <Expression>NG_012283.1:g.33318dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001161504.2" sequenceAccession="NM_001161504" sequenceVersion="2" change="c.1380dup">
            <Expression>NM_001161504.2:c.1380dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001154976.1" sequenceAccession="NP_001154976" sequenceVersion="1" change="p.Gly461fs">
            <Expression>NP_001154976.1:p.Gly461fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001319218.2" sequenceAccession="NM_001319218" sequenceVersion="2" change="c.1407dup">
            <Expression>NM_001319218.2:c.1407dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001306147.1" sequenceAccession="NP_001306147" sequenceVersion="1" change="p.Gly470fs">
            <Expression>NP_001306147.1:p.Gly470fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003748.4" sequenceAccession="NM_003748" sequenceVersion="4" change="c.1560dup" MANESelect="true">
            <Expression>NM_003748.4:c.1560dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003739.2" sequenceAccession="NP_003739" sequenceVersion="2" change="p.Gly521fs">
            <Expression>NP_003739.2:p.Gly521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_170726.3" sequenceAccession="NM_170726" sequenceVersion="3" change="c.1560dup">
            <Expression>NM_170726.3:c.1560dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_733844.1" sequenceAccession="NP_733844" sequenceVersion="1" change="p.Gly521fs">
            <Expression>NP_733844.1:p.Gly521fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003748.4" sequenceAccession="NM_003748" sequenceVersion="4" change="c.1560dupT" MANESelect="true">
            <Expression>NM_003748.4:c.1560dupT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="779536510" DB="dbSNP" />
        <XRef ID="CA212813" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606811.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9700195 Fig. 2D to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003748.4(ALDH4A1):c.1560dup (p.Gly521fs) AND Hyperprolinemia type 2" Accession="RCV000004209" Version="9">
        <ClassifiedConditionList TraitSetID="1095">
          <ClassifiedCondition DB="MedGen" ID="C2931835">Hyperprolinemia type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-22" SubmissionCount="3">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003748.4(ALDH4A1):c.1560dup (p.Gly521fs) AND not provided" Accession="RCV001092591" Version="20">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-06-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-22" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2015-03-16" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2624476</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9700195</ID>
        </Citation>
        <DescriptionHistory Dated="2023-03-04">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1095" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1743" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hyperprolinemia type 2</ElementValue>
                <XRef ID="MONDO:0009401" DB="MONDO" />
                <XRef ID="717181004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Delta-1-pyrroline-5-carboxylate dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0022953" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">1-PYRROLINE-5-CARBOXYLATE DEHYDROGENASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="239510" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of pyrroline-5-carboxylate reductase</ElementValue>
                <XRef ID="Deficiency+of+pyrroline-5-carboxylate+reductase/8202" DB="Genetic Alliance" />
                <XRef ID="124177001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HPII</ElementValue>
                <XRef Type="MIM" ID="239510" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HYRPRO2</ElementValue>
                <XRef Type="MIM" ID="239510" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6710" />
                <XRef ID="6710" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="79101" DB="Orphanet" />
              <XRef ID="C2931835" DB="MedGen" />
              <XRef ID="MONDO:0009401" DB="MONDO" />
              <XRef Type="MIM" ID="239510" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24375" SubmissionDate="2015-03-11" DateLastUpdated="2015-03-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606811.0001_HYPERPROLINEMIA, TYPE II" title="ALDH4A1, 1-BP INS, 1563T_HYPERPROLINEMIA, TYPE II" />
        <ClinVarAccession Accession="SCV000024375" DateUpdated="2015-03-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Geraghty et al. (1998) demonstrated a frameshift mutation in the ALDH4 gene in homozygous state in affected members of a large pedigree of Irish travelers, a distinct nomadic group within the Irish population with many individuals affected by hyperprolinemia type II (HYRPRO2; 239510) (Flynn et al., 1989). Approximately 70% of affected members of this pedigree had childhood febrile seizures but mental handicap was not a feature. In one segment of the pedigree the father and 6 of 7 children were all homozygous for the mutant allele, the mother was heterozygous, and 1 unaffected child was heterozygous. The mutation consisted of insertion of a T following nucleotide 1563 and causing a frameshift at codon gly521.</Attribute>
              <Citation>
                <ID Source="PubMed">9700195</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">2624476</ID>
              </Citation>
              <XRef DB="OMIM" ID="239510" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH4A1" />
          </GeneList>
          <Name>ALDH4A1, 1-BP INS, 1563T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1563T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606811.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPERPROLINEMIA, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7139109" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="dd95e11fbe6546984eff87ae6eab9c4bad8cae7a6b745b0b58a7145b4463b7eb|OMIM:239510" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003831810" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003748.4:c.1560dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="239510" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9757544" SubmissionDate="2024-06-29" DateLastUpdated="2024-07-07" DateCreated="2024-05-07">
        <ClinVarSubmissionID localKey="NM_003748.4:c.1560dupT|MedGen:C2931835" />
        <ClinVarAccession Accession="SCV005039240" DateUpdated="2024-07-07" DateCreated="2024-05-07" Type="SCV" Version="2" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9700195</ID>
          </Citation>
          <Comment>Variant summary: ALDH4A1 c.1560dupT (p.Gly521TrpfsX10) results in a premature termination codon, predicted to cause a truncation of the encoded protein, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 1.2e-05 in 250726 control chromosomes. c.1560dupT has been reported in the literature in the homozygous state in multiple members of a family affected with hyperprolinemia type II (Geraghty_1998). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (Geraghty_1998). The variant was determined to result in an absence of growth on proline and absent enzymatic activity compared to wild-type in a yeast expression assay. The following publication has been ascertained in the context of this evaluation (PMID: 9700195). ClinVar contains an entry for this variant (Variation ID: 4002). Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH4A1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003748.4:c.1560dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931835" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>clinvar-submission.2024-03.anno.csv</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2470752" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="102107|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001249153" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ALDH4A1: PP1:Strong, PVS1:Strong, PM2, PM3, PS3:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH4A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="CA" referenceAllele="C" start="19200975" stop="19200975" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5392495" SubmissionDate="2022-11-30" DateLastUpdated="2022-12-03" DateCreated="2022-12-03">
        <ClinVarSubmissionID localKey="GDXSV:249834" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002757568" DateUpdated="2022-12-03" DateCreated="2022-12-03" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Published functional studies demonstrate a damaging effect as the variant abolished P5CDh activity in yeast cells (Geraghty et al., 1998); Not observed at significant frequency in large population cohorts (gnomAD); Frameshift variant predicted to result in protein truncation, as the last 43 amino acids are replaced with 9 different amino acids in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 9700195)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALDH4A1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:2705632</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003748.3:c.1560dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_147_20221130054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24375" TraitType="Disease" MappingType="Name" MappingValue="HYPERPROLINEMIA, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C2931835" Name="Hyperprolinemia type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5392495" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2470752" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9757544" TraitType="Disease" MappingType="XRef" MappingValue="C2931835" MappingRef="MedGen">
        <MedGen CUI="C2931835" Name="Hyperprolinemia type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7139109" TraitType="Disease" MappingType="XRef" MappingValue="239510" MappingRef="OMIM">
        <MedGen CUI="C2931835" Name="Hyperprolinemia type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

